• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Electrospun Aligned Coaxial Nanofibrous Scaffold for Cardiac Repair.用于心脏修复的静电纺丝定向同轴纳米纤维支架。
Methods Mol Biol. 2021;2193:129-140. doi: 10.1007/978-1-0716-0845-6_13.
2
Three-dimensional poly-(ε-caprolactone) nanofibrous scaffolds directly promote the cardiomyocyte differentiation of murine-induced pluripotent stem cells through Wnt/β-catenin signaling.三维聚(ε-己内酯)纳米纤维支架通过Wnt/β-连环蛋白信号通路直接促进小鼠诱导多能干细胞向心肌细胞分化。
BMC Cell Biol. 2015 Sep 3;16:22. doi: 10.1186/s12860-015-0067-3.
3
In situ differentiation of human-induced pluripotent stem cells into functional cardiomyocytes on a coaxial PCL-gelatin nanofibrous scaffold.人诱导多能干细胞在同轴聚己内酯-明胶纳米纤维支架上原位分化为功能性心肌细胞
Mater Sci Eng C Mater Biol Appl. 2021 Jan;118:111354. doi: 10.1016/j.msec.2020.111354. Epub 2020 Aug 11.
4
Compatibility and function of human induced pluripotent stem cell derived cardiomyocytes on an electrospun nanofibrous scaffold, generated from an ionomeric polyurethane composite.人诱导多能干细胞来源的心肌细胞在电纺纳米纤维支架上的相容性和功能,该支架由离聚物聚氨酯复合材料制成。
J Biomed Mater Res A. 2022 Dec;110(12):1932-1943. doi: 10.1002/jbm.a.37428. Epub 2022 Jul 19.
5
PGS:Gelatin nanofibrous scaffolds with tunable mechanical and structural properties for engineering cardiac tissues.PGS:具有可调机械和结构性能的明胶纳米纤维支架,用于工程心脏组织。
Biomaterials. 2013 Sep;34(27):6355-66. doi: 10.1016/j.biomaterials.2013.04.045. Epub 2013 Jun 6.
6
Evaluation of Changes in Morphology and Function of Human Induced Pluripotent Stem Cell Derived Cardiomyocytes (HiPSC-CMs) Cultured on an Aligned-Nanofiber Cardiac Patch.在排列纳米纤维心脏补片上培养的人诱导多能干细胞衍生心肌细胞(HiPSC-CMs)的形态和功能变化评估
PLoS One. 2015 May 19;10(5):e0126338. doi: 10.1371/journal.pone.0126338. eCollection 2015.
7
Scalable Biomimetic Coaxial Aligned Nanofiber Cardiac Patch: A Potential Model for "Clinical Trials in a Dish".可扩展的仿生同轴排列纳米纤维心脏贴片:“盘中临床试验”的潜在模型
Front Bioeng Biotechnol. 2020 Sep 16;8:567842. doi: 10.3389/fbioe.2020.567842. eCollection 2020.
8
Human Pluripotent Stem Cell-Derived Cardiac Tissue-like Constructs for Repairing the Infarcted Myocardium.人多能干细胞衍生的类心肌组织构建物用于修复梗死的心肌。
Stem Cell Reports. 2017 Nov 14;9(5):1546-1559. doi: 10.1016/j.stemcr.2017.09.007. Epub 2017 Oct 26.
9
Guided orientation of cardiomyocytes on electrospun aligned nanofibers for cardiac tissue engineering.引导心肌细胞在静电纺丝对齐纳米纤维上取向用于心脏组织工程。
J Biomed Mater Res B Appl Biomater. 2011 Aug;98(2):379-86. doi: 10.1002/jbm.b.31862. Epub 2011 Jun 16.
10
Maturation of human cardiomyocytes derived from induced pluripotent stem cells (iPSC-CMs) on polycaprolactone and polyurethane nanofibrous mats.人诱导多能干细胞(iPSC-CMs)来源的心肌细胞在聚己内酯和聚氨酯纳米纤维垫上的成熟。
Sci Rep. 2024 Jun 5;14(1):12975. doi: 10.1038/s41598-024-63905-z.

引用本文的文献

1
Cardiac Tissue Engineering for Translational Cardiology: From In Vitro Models to Regenerative Therapies.用于转化心脏病学的心脏组织工程:从体外模型到再生疗法
Bioengineering (Basel). 2025 May 14;12(5):518. doi: 10.3390/bioengineering12050518.
2
Advances and Prospects in Using Induced Pluripotent Stem Cells for 3D Bioprinting in Cardiac Tissue Engineering.诱导多能干细胞在心脏组织工程3D生物打印中的研究进展与展望
Rev Cardiovasc Med. 2025 Mar 19;26(3):26697. doi: 10.31083/RCM26697. eCollection 2025 Mar.
3
Living Nanofiber-Enabled Cardiac Patches for Myocardial Injury.用于心肌损伤的具有活性纳米纤维的心脏贴片
JACC Basic Transl Sci. 2025 Feb;10(2):227-240. doi: 10.1016/j.jacbts.2024.06.010. Epub 2024 Sep 4.
4
Next-generation pediatric care: nanotechnology-based and AI-driven solutions for cardiovascular, respiratory, and gastrointestinal disorders.下一代儿科护理:基于纳米技术和人工智能驱动的心血管、呼吸和胃肠道疾病解决方案。
World J Pediatr. 2025 Jan;21(1):8-28. doi: 10.1007/s12519-024-00834-x. Epub 2024 Aug 28.
5
Advances in the design, generation, and application of tissue-engineered myocardial equivalents.组织工程心肌替代物在设计、生成及应用方面的进展
Front Bioeng Biotechnol. 2023 Sep 22;11:1247572. doi: 10.3389/fbioe.2023.1247572. eCollection 2023.
6
Cells and Materials for Cardiac Repair and Regeneration.用于心脏修复和再生的细胞与材料
J Clin Med. 2023 May 10;12(10):3398. doi: 10.3390/jcm12103398.
7
A Review on the Applications of Natural Biodegradable Nano Polymers in Cardiac Tissue Engineering.天然可生物降解纳米聚合物在心脏组织工程中的应用综述
Nanomaterials (Basel). 2023 Apr 15;13(8):1374. doi: 10.3390/nano13081374.
8
Development of 3D Printed Electrospun Scaffolds for the Fabrication of Porous Scaffolds for Vascular Applications.用于制造血管应用多孔支架的3D打印电纺支架的开发。
3D Print Addit Manuf. 2022 Oct 1;9(5):380-388. doi: 10.1089/3dp.2020.0337. Epub 2022 Oct 10.
9
Cardiac tissue engineering: Multiple approaches and potential applications.心脏组织工程:多种方法及潜在应用
Front Bioeng Biotechnol. 2022 Oct 3;10:980393. doi: 10.3389/fbioe.2022.980393. eCollection 2022.
10
Artificial Scaffolds in Cardiac Tissue Engineering.心脏组织工程中的人工支架
Life (Basel). 2022 Jul 25;12(8):1117. doi: 10.3390/life12081117.

本文引用的文献

1
Assessment of temporal functional changes and miRNA profiling of human iPSC-derived cardiomyocytes.人诱导多能干细胞来源心肌细胞的时间功能变化评估和 miRNA 谱分析。
Sci Rep. 2019 Sep 12;9(1):13188. doi: 10.1038/s41598-019-49653-5.
2
Current research trends and challenges in tissue engineering for mending broken hearts.修复破碎心脏的组织工程学的当前研究趋势和挑战。
Life Sci. 2019 Jul 15;229:233-250. doi: 10.1016/j.lfs.2019.05.012. Epub 2019 May 17.
3
Cardiac tissue engineering: current state-of-the-art materials, cells and tissue formation.心脏组织工程:当前的先进材料、细胞与组织形成
Einstein (Sao Paulo). 2018 Sep 21;16(3):eRB4538. doi: 10.1590/S1679-45082018RB4538.
4
Inflammatory response and biomechanical properties of coaxial scaffolds for engineered skin in vitro and post-grafting.用于体外构建工程皮肤和移植后皮肤的同轴支架的炎症反应和生物力学特性。
Acta Biomater. 2018 Oct 15;80:247-257. doi: 10.1016/j.actbio.2018.09.014. Epub 2018 Sep 12.
5
The effect of the carbodiimide cross-linker on the structural and biocompatibility properties of collagen-chondroitin sulfate electrospun mat.碳二亚胺交联剂对胶原-硫酸软骨素电纺垫结构和生物相容性性质的影响。
Int J Nanomedicine. 2018 Jul 30;13:4405-4416. doi: 10.2147/IJN.S165739. eCollection 2018.
6
Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future.简明综述:心脏细胞疗法是否已死?令人尴尬的试验结果与未来的新方向。
Stem Cells Transl Med. 2018 Apr;7(4):354-359. doi: 10.1002/sctm.17-0196. Epub 2018 Feb 22.
7
Transplantation of Human Embryonic Stem Cell-Derived Cardiovascular Progenitors for Severe Ischemic Left Ventricular Dysfunction.人胚干细胞衍生心血管祖细胞移植治疗严重缺血性左心室功能障碍。
J Am Coll Cardiol. 2018 Jan 30;71(4):429-438. doi: 10.1016/j.jacc.2017.11.047.
8
Large Cardiac Muscle Patches Engineered From Human Induced-Pluripotent Stem Cell-Derived Cardiac Cells Improve Recovery From Myocardial Infarction in Swine.由人诱导多能干细胞衍生的心肌细胞构建的大型心肌斑块可改善猪心肌梗死后的恢复。
Circulation. 2018 Apr 17;137(16):1712-1730. doi: 10.1161/CIRCULATIONAHA.117.030785. Epub 2017 Dec 12.
9
Artificial Cardiac Muscle with or without the Use of Scaffolds.具有或不具有支架的人工心脏肌肉。
Biomed Res Int. 2017;2017:8473465. doi: 10.1155/2017/8473465. Epub 2017 Aug 10.
10
Tunable engineered skin mechanics via coaxial electrospun fiber core diameter.通过同轴电纺纤维芯直径实现可调节的工程皮肤力学性能。
Tissue Eng Part A. 2014 Oct;20(19-20):2746-55. doi: 10.1089/ten.TEA.2013.0687. Epub 2014 May 20.

用于心脏修复的静电纺丝定向同轴纳米纤维支架。

Electrospun Aligned Coaxial Nanofibrous Scaffold for Cardiac Repair.

机构信息

Department of Emergency Medicine, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

Dorothy M. Davis Heart & Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH, USA.

出版信息

Methods Mol Biol. 2021;2193:129-140. doi: 10.1007/978-1-0716-0845-6_13.

DOI:10.1007/978-1-0716-0845-6_13
PMID:32808265
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7487206/
Abstract

Cardiovascular diseases (CVDs) are one of the leading causes of mortality worldwide and a number one killer in the USA. Cell-based approaches to treat CVDs have only shown modest improvement due to poor survival, retention, and engraftment of the transplanted cells in the ischemic myocardium. Recently, tissue engineering and the use of 3D scaffolds for culturing and delivering stem cells for ischemic heart disease are gaining rapid potential. Here, we describe a protocol for the fabrication of aligned coaxial nanofibrous scaffold comprising of a polycaprolactone (PCL) core and gelatin shell. Furthermore, we describe a detailed protocol for the efficient seeding and maintenance of human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs) on these nanofibrous scaffolds, which could have a potential application in the generation of functional "cardiac patch" for myocardial repair applications as well as an in vitro 3D cardiac tissue model to evaluate the efficacy of cardiovascular drugs and cardiac toxicities.

摘要

心血管疾病 (CVDs) 是全球范围内导致死亡的主要原因之一,也是美国的头号杀手。由于移植细胞在缺血性心肌中的存活率、保留率和植入率低,基于细胞的方法治疗 CVDs 仅取得了适度的改善。最近,组织工程和使用 3D 支架培养和输送用于缺血性心脏病的干细胞正在迅速获得潜力。在这里,我们描述了一种制造包含聚己内酯 (PCL) 核和明胶壳的定向同轴纳米纤维支架的方案。此外,我们还描述了一种详细的方案,用于在这些纳米纤维支架上高效接种和维持人诱导多能干细胞衍生的心肌细胞 (hiPSC-CMs),这可能在生成功能性“心脏贴片”用于心肌修复应用以及评估心血管药物疗效和心脏毒性的体外 3D 心脏组织模型方面具有潜在应用。